背景:外阴癌和阴道癌是相对罕见的肿瘤,在日本还没有建立治疗这些罕见肿瘤的治疗原则或指南.日本妇科肿瘤学会(JSGO)治疗外阴癌和阴道癌指南的第一版于2015年在日本出版。
目的:JSGO委员会决定在全球范围内发布JSGO指南的英文版,并希望它将是一个有用的指导医生在类似的情况下,日本。
方法:该指南是根据创建JSGO指南的基本原理创建的。
结果:指南由五个章节和五个算法组成。在第一章之前,描述了基本项目,包括分期分类和历史记录,组织学分类,以及手术方法的定义,辐射,和化疗,让读者更好地理解这些罕见肿瘤的指南内容。第一章对准则进行了概述,包括基本方针。第二章讨论外阴癌,第三章讨论阴道癌,第四章讨论了外阴Paget病和恶性黑色素瘤。每章包括临床问题,recommendations,背景,目标,解释,和参考。第五章为临床问题解释中提到的药物提供了补充数据。
结论:总体而言,本指南的目的是明确界定外阴癌和阴道癌的护理标准,目的是确保为所有被诊断患有这些罕见疾病的妇女提供高标准的护理.
BACKGROUND: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO)
guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese.
OBJECTIVE: The JSGO committee decided to publish the English version of the JSGO
guidelines worldwide, and hope it will be a useful guide to physicians in a similar situation as in Japan.
METHODS: The
guideline was created according to the basic principles in creating the
guidelines of JSGO.
RESULTS: The
guidelines consist of five chapters and five algorithms. Prior to the first chapter, basic items are described including staging classification and history, classification of histology, and definition of the methods of surgery, radiation, and chemotherapy to give the reader a better understanding of the contents of the guidelines for these rare tumors. The first chapter gives an overview of the
guidelines, including the basic policy of the
guidelines. The second chapter discusses vulvar cancer, the third chapter discusses vaginal cancer, and the fourth chapter discusses vulvar Paget\'s disease and malignant melanoma. Each chapter includes clinical questions, recommendations, backgrounds, objectives, explanations, and references. The fifth chapter provides supplemental data for the drugs that are mentioned in the explanation of clinical questions.
CONCLUSIONS: Overall, the objective of these guidelines is to clearly delineate the standard of care for vulvar and vaginal cancer with the goal of ensuring a high standard of care for all women diagnosed with these rare diseases.